The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): Assumptions about sexual risk compensation and implications for access

AIDS and Behavior

Volumn 18, Issue 2, 2014, Pages 226-240

  Calabrese, Sarah K ^a   Earnshaw, Valerie A ^a   Underhill, Kristen ^a   Hansen, Nathan B ^a,b   Dovidio, John F ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Healthcare provider; Men who have sex with men (MSM); Pre exposure prophylaxis (PrEP); Race ethnicity; Risk compensation

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ATTITUDE TO HEALTH; BLACK PERSON; CAUCASIAN; CULTURAL COMPETENCE; DECISION MAKING; ETHNOLOGY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUALITY; MEDICAL STUDENT; PREJUDICE; PRESCRIPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RACISM; SOCIOECONOMICS; STATISTICS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; ANTIBIOTIC PROPHYLAXIS; ATTITUDE OF HEALTH PERSONNEL; CULTURAL COMPETENCY; DECISION MAKING; DRUG PRESCRIPTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PREJUDICE; QUESTIONNAIRES; RACISM; SOCIOECONOMIC FACTORS; STUDENTS, MEDICAL;

EID: 84893868110     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0675-x     Document Type: Review

References (96)

1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.
2. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423-34.
3. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
4. US Food and Drug Administration. FDA News Release: FDA approves first drug for reducing the risk of sexually acquired HIV infection. 2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm. Accessed 1 Oct 2013.
5. Hogben M, Liddon N. Disinhibition and risk compensation: scope, definitions, and perspective. Sex Transm Dis. 2008;35(12):1009-10.
6. Tripathi A, Ogbuanu C, Monger M, Gibson JJ, Duffus WA. Preexposure prophylaxis for HIV infection: healthcare providers' knowledge, perception, and willingness to adopt future implementation in the southern US. South Med J. 2012;105(4):199-206.
7. Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(3):65-8.
8. Centers for Disease Control and Prevention. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012;61(31):586-9.
9. Centers for Disease Control and Prevention. Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep. 2013;62(23):463-5.
10. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html. Accessed 1 Oct 2013.
11. World Health Organization. Guidance on pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva: World Health Organization; 2012.
12. Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012;7(7):e40603.
13. Puro V, Palummieri A, De Carli G, Piselli P, Ippolito G. Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists. BMC Infect Dis. 2013;13(1):217-24.
14. Bowleg L, Teti M, Massie JS, Patel A, Malebranche DJ, Tschann JM. 'What does it take to be a man? What is a real man?': ideologies of masculinity and HIV sexual risk among Black heterosexual men. Cult Health Sex. 2011;13(5):545-59.
15. Bowleg L. "Once you've blended the cake, you can't take the parts back to the main ingredients": Black gay and bisexual men's descriptions and experiences of intersectionality. Sex Roles. 2013;68(11-12):754-67.
16. Valentine JA. Impact of attitudes and beliefs regarding African American sexual behavior on STD prevention and control in African American communities: unintended consequences. Sex Transm Dis. 2008;35(12):S23-9.
17. Bogart LM, Catz SL, Kelly JA, Benotsch EG. Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making. 2001;21(1):28-36. (Pubitemid 32245028)
18. King WD, Wong MD, Shapiro MF, Landon BE, Cunningham WE. Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors? J Gen Intern Med. 2004;19(11):1146-53. (Pubitemid 39552585)
19. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States - results from the HIV cost and services utilization study. JAMA. 1999;281(24):2305-15. (Pubitemid 29289823)
20. Stone VE. Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence. Curr HIV/AIDS Rep. 2005;2:189-93.
21. Harrison DD, Cooke CW. An elucidation of factors influencing physicians' willingness to perform elective female sterilization. Obstet Gynecol. 1988;72(4):565-70.
22. Borrero S, Schwarz EB, Creinin M, Ibrahim S. The impact of race and ethnicity on receipt of family planning services in the United States. J Womens Health. 2009;18(1):91-6.
23. D'Amore MM, Cheng DM, Allensworth-Davies D, Samet JH, Saitz R. Disparities in safe sex counseling & behavior among individuals with substance dependence: a cross-sectional study. Reprod Health. 2012;9:35.
24. Downing RA, LaVeist TA, Bullock HE. Intersections of ethnicity and social class in provider advice regarding reproductive health. Am J Public Health. 2007;97(10):1803-7. (Pubitemid 351182289)
25. Gilead Sciences Inc. Truvada: Risk Evaluation and Mitigation Strategy. http://www.fda.gov/downloads/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatiePostmarketDrugS/UCM312304.pdf. Accessed 1 Oct 2013.
26. Abdool Karim SS, Gray GE, Martinson N. Clinical decisions. Preexposure prophylaxis for HIV prevention. N Engl J Med. 2012;367(5):462-5.
27. Maznavi K, Hardy D, Bredeek F. Pre-exposure prophylaxis (PrEP) for HIV: an online survey of HIV healthcare providers evaluating their knowledge, perception, and prescription of PrEP. Boston: Infectious Diseases Society of America Annual Meeting; 2011.
28. Gaertner SL, Dovidio JF. Understanding and addressing contemporary racism: from aversive racism to the common ingroup identity model. J Soc Issues. 2005;61(3):615-39. (Pubitemid 41794896)
29. Aberson CL, Ettlin TE. The aversive racism paradigm and responses favoring African Americans: meta-analytic evidence of two types of favoritism. Soc Justice Res. 2004;17(1):25-46. (Pubitemid 39046560)
30. Dovidio JF, Gaertner SL. Aversive racism. Adv Exp Soc Psychol. 2004;36:1-52. (Pubitemid 39753654)
31. Geiger HJ. Racial and ethnic disparities in diagnosis and treatment: a review of the evidence and a consideration of causes. In: Smedley A, Stith A, Nelson A, editors. Unequal treatment: donfronting racial and ethnic disparities in health care. Washington, DC: National Academic Press; 2003. p. 417-54.
32. Dovidio JF, Penner LA, Albrecht TL, Norton WE, Gaertner SL, Shelton JN. Disparities and distrust: the implications of psychological processes for understanding racial disparities in health and health care. Soc Sci Med. 2008;67(3):478-86.
33. Dovidio JF, Fiske ST. Under the radar: how unexamined biases in decision-making processes in clinical interactions can contribute to health care disparities. Am J Public Health. 2012;102(5):945-52.
34. Thorner AR, Rosenberg ES. Early versus delayed antiretroviral therapy in patients with HIV infection - a review of the current guidelines from an immunological perspective. Drugs. 2003;63(13):1325-37. (Pubitemid 36776090)
35. Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH. Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts. AIDS Care. 2013. Epub 2013/10/15.
36. White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDs. 2012;26(7):395-405.
37. Senn H, Wilton J, Sharma M, Fowler S, Tan DH. Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. AIDS Res Hum Retroviruses. 2013;29(9):1183-9.
38. Hedlund J. Risky business: safety regulations, risk compensation, and individual behavior. Inj Prev. 2000;6:82-90.
39. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. 2006;332(7541):605-7. (Pubitemid 44365764)
40. Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4(4):165-72.
41. Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54(5):548-55.
42. Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Educ Prev. 2012;24(5):408-21.
43. Underhill K, Morrow KM, Operario D, Ducharme R, Kuo C, Mayer KH. Project PrEP talk: an in-depth qualitative analysis of PrEP acceptability, expectations and risk compensation beliefs among United States MSM. XIX International AIDS Conference. Washington, DC, 2012.
44. Krakower D, Mimiaga M, Rosenberger J et al. Anticipated risk compensation with pre-exposure prophylaxis use among North American men who have sex with men using an internet social network. XIX International AIDS Conference. Washington, DC, 2012.
45. Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26(2):87-94.
46. Koblin BA, Mansergh G, Frye V, et al. Condom-use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX. J Acquir Immune Defic Syndr. 2011;58(3):319-27.
47. Paltiel AD, Freedberg KA, Scott CA, et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:806-15.
48. Desai K, Sansom SL, Ackers ML, Stewart SR, Hall HI, Hu DJ, et al. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS. 2008;22:1829-39.
49. Gray R, Kigozi G, Kong X, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS. 2012;26(5):609-15.
50. Kong X, Kigozi G, Nalugoda F, et al. Assessment of changes in risk behaviors during 3 years of posttrial follow-up of male circumcision trial participants uncircumcised at trial closure in Rakai, Uganda. Am J Epidemiol. 2012;176(10):875-85.
51. Kalichman S, Eaton L, Pinkerton S. Circumcision for HIV prevention: failure to fully account for behavioral risk compensation. PLoS Med. 2007;4(3):e138. (Pubitemid 46495330)
52. Gust DA, Kretsinger K, Pals SL, Gaul ZJ, Hefflefinger JD, Begley EB, et al. Male circumcision as an HIV prevention intervention in the US: influence of health care providers and potential for risk compensation. Prev Med. 2011;52(3-4):270-3.
53. Pinkerton SD. Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal. 2001;21(4):727-36. (Pubitemid 34101539)
54. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292(2):224-36. (Pubitemid 38918000)
55. Guest G, Shattuck D, Johnson L, et al. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Sex Transm Dis. 2008;35(12):1002-8.
56. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411-22.
57. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083-90.
58. Underhill K. Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: balancing methodological rigor and research ethics. Soc Sci Med. 2013;94:115-23.
59. Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, et al. Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis. 2013. Epub 2013/10/22.
60. Greenwald AG, Banaji MR. Implicit social cognition: attitudes, self-esteem, and stereotypes. Psychol Rev. 1995;102(1):4-27.
61. Jost JT, Banaji MR. The role of stereotyping in system-justification and the production of false consciousness. Br J Soc Psychol. 1994;33:1-27.
62. Thorburn S, Bogart LM. African American women and family planning services: perceptions of discrimination. Women Health. 2005;42(1):23-39.
63. Saleh LD, Operario D. Moving beyond "the Down Low": a critical analysis of terminology guiding HIV prevention efforts for African American men who have secretive sex with men. Soc Sci Med. 2009;68(2):390-5.
64. Ford CL, Whetten KD, Hall SA, Kaufman JS, Thrasher AD. Black sexuality, social construction, and research targeting 'the Down Low' ('the DL'). Ann Epidemiol. 2007;17(3):209-16.
65. Millett GA, Peterson JL, Flores SA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341-8.
66. Millett GA, Peterson JL, Wolitski RJ, Stall R. Greater risk for HIV infection of black men who have sex with men: a critical literature review. Am J Public Health. 2006;96(6):1007-19. (Pubitemid 43833153)
67. Feldman MB. A critical literature review to identify possible causes of higher rates of HIV infection among young Black and Latino men who have sex with men. J Natl Med Assoc. 2010;102(12):1206-21.
68. Young S. Panel recommends approving Truvada to prevent HIV infection CNN Health. 2012 July 16. http://www.cnn.com/2012/05/10/health/hiv-drug. Accessed 1 Oct 2013.
69. AIDS Healthcare Foundation. AHF asks, "What's rotten at FDA" in new Politico Playbook ads 2012. http://www.aidshealth.org/archives/news/ahf- asks-whats-rotten-at-fda-in-politico-playbook. Accessed 1 Oct 2013.
70. Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods. 2002;7(4):422-45.
71. Hayes AF. Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun Monogr. 2009;76(4):408-20.
72. Hayes AF. An introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Press; 2013.
73. MacKinnon DP, Fairchild AJ. Current Directions in Mediation Analysis. Curr Dir Psychol Sci. 2009;18(1):16-20.
74. Malebranche DJ, Peterson JL, Fullilove RE, Stackhouse RW. Race and sexual identity: perceptions about medical culture and healthcare among Black men who have sex with men. J Natl Med Assoc. 2004;96(1):97-107. (Pubitemid 38095690)
75. Amodio DM, Devine PG. Stereotyping and evaluation in implicit race bias: evidence for independent constructs and unique effects on behavior. J Pers Soc Psychol. 2006;91(4):652-61. (Pubitemid 44600892)
76. Amodio DM, Ratner KG. A memory systems model of implicit social cognition. Curr Dir Psychol Sci. 2011;20(3):143-8.
77. Mera RM, Rawlings MK, Pechonkina A, Rooney JF, Peschel T, Cheng A. Status of Truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) in the United States: an early drug utilization analysis. Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, 2013.
78. Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K. Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr. 2010;55(1):8-13.
79. Wheeler ME, Fiske ST. Controlling racial prejudice: social-cognitive goals affect amygdala and stereotype activation. Psychol Sci. 2005;16(1):56-63. (Pubitemid 40176528)
80. Burgess D, van Ryn M, Dovidio J, Saha S. Reducing racial bias among health care providers: lessons from social-cognitive psychology. J Gen Intern Med. 2007;22(6):882-7. (Pubitemid 46763968)
81. Penner LA, Gaertner S, Dovidio JF, et al. A social psychological approach to improving the outcomes of racially discordant medical interactions. J Gen Intern Med. 2013;28(9):1143-9.
82. Burgess DJ. Addressing racial healthcare disparities: how can we shift the focus from patients to providers? J Gen Intern Med. 2011;26(8):828-30.
83. Teal CR, Shada RE, Gill AC, et al. When best intentions aren't enough: helping medical students develop strategies for managing bias about patients. J Gen Intern Med. 2010;25(Suppl 2):S115-8.
84. Boutin-Foster C, Foster JC, Konopasek L. Viewpoint: physician, know thyself: the professional culture of medicine as a framework for teaching cultural competence. Acad Med. 2008;83(1):106-11.
85. Novack DH, Epstein RM, Paulsen RH. Toward creating physician-healers: fostering medical students' self-awareness, personal growth, and well-being. Acad Med. 1999;74(5):516-20. (Pubitemid 29240982)
86. Newheiser AK, Dovidio JF. Individual differences and intergroup bias: divergent dynamics associated with prejudice and stereotyping. Pers Individ Dif. 2012;53(1):70-4.
87. Greenwald AG, Poehlman TA, Uhlmann EL, Banaji MR. Understanding and using the implicit association test: III. Meta-analysis of predictive validity. J Pers Soc Psychol. 2009;97(1):17-41.
88. Veloski J, Tai S, Evans AS, Nash DB. Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual. 2005;20(3):151-7. (Pubitemid 40880390)
89. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA. 2000;283(13):1715-22. (Pubitemid 30196212)
90. Singh JA. Antiretroviral resource allocation for HIV prevention. AIDS. 2013;27(6):863-5.
91. Cohen SE, Liu AY, Bernstein KT, Philip S. Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis. Am J Prev Med. 2013;44(Suppl 2):S80-5.
92. Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7:116.
93. Jay JS, Gostin LO. Ethical challenges of preexposure prophylaxis for HIV. JAMA. 2012;308(9):867-8.
94. Rennie S. Ethical use of antiretroviral resources for HIV prevention in resource poor settings. Dev World Bioeth. 2013;13(2):79-86.
95. Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210-9.
96. Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7(6):593-9.